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Summary The aim of the present study was to evaluate the prognostic factors of bilharzial bladder cancer
treated by radical cystectomy: good prognosis is defined as a survival of more than one year, free of local
recurrence or metastasis. Two groups of 155 patients, one with a good prognosis (GPG) and the other with a
bad prognosis (BPG), through the period 1977-1983 at the National Cancer Institute of Cairo were
systematically analyzed for 13 variables evaluated at the commencement of the one year follow-up. Nine
factors proved to be of high prognostic value: age, tumour stage, size, grade and location in the bladder,
lymph node involvement, metastasis, renal insufficiency and type of urinary diversion. Four variables
appeared not to have prognostic value viz: sex, type of tumour (multiplicity), histopathology, and presence of
ova of schistosoma haematobium in the specimen.
Using a discriminant analysis technique to take into account the inter-relationships between the factors, it
was found that tumour grade was the most important prognostic factor followed, in order of importance, by
tumour stage, renal insufficiency, size of the tumour and lymph node involvement. Moreover, a simplified
score for prognosis was determined: X= 10 grade (1 to 3)+5 stage (1 to 4)+6 renal insufficiency (Y/N)+1
diameter of the tumour (cm)+4 lymph node involvement (Y/N). The larger the score, the poorer the
prognosis.
Bladder cancer occurs with high frequency in some parts of
Africa and the Middle East. Egypt has very likely the highest
frequency in the Middle East. Moreover, in Egypt, this type
of cancer represents roughly 20% of the total cancer
incidence. It is the most frequent cancer in males and the
second most common neoplasm (after breast cancer) in
females (Ibrahim, 1981).
Because of the similarity in geographic distribution of
bladder cancer and endemic schistosomiasis, a causal
relationship was long suspected and subsequently established
between the two diseases. This association defines a distinct
clinicopathologic entity of bladder cancer quite different
from that experienced in the Western world (El-Sebai, 1981).
The tumour is found mostly in relatively young age
groups.
- The patients usually present in an advanced stage of the
disease with symptoms of cystitis.
It is commonly a well differentiated squamous carcinoma
with a limited tendency to lymphatic and blood stream
spread.
The trigone is rarely affected.
The more common treatment is radical cystectomy with
urinary diversion (El-Sebai, 1981). The decision to undertake
radical cystectomy is taken on clinical grounds according to
the TNM pre-operative clinical classification. T2 and T3
cases are treated by radical cystectomy. T4 cases comprise
those patients with fixed tumour or tumours extending to
neighbouring structures (infiltration of the prostate, uterus
or vagina and/or fixation to the pelvic wall and/or
abdominal wall). Patients belonging to this category are
considered explorable and given the chance of surgical
intervention if they present in a fair general condition with
no marked evidence of posterolateral fixity. Cases proven to
be inoperable following exploration are treated by
chemotherapy (El-Sebai, 1983).
Recurrence after surgery occurs locally in the pelvis and
90.6% of the recurrences occur during the first postoperative
year (El-Bolkainy & Chu, 1981).
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The aim of the study was first to determine in the case of
bilharzial bladder cancer the prognostic value of factors that
have been previously demonstrated as prognostic factors in
bladder cancer. Second, to assess a discriminant function
with a minimum number of variables that would efficiently
predict a good prognosis for one year at least after radical
cystectomy.
Materials and methods
Data were collected from subjects aged more than 20 years
with bladder cancer associated with schistosomiasis (as
evidenced by urine detection of ova of schistosoma haema-
tobium or history), who underwent radical cystectomy in the
period January 1977 to December 1983 at the National
Cancer Institute (NCI) of Cairo and had a complete follow
up for at least one year after surgery. The total number of
bladder cancer cases in this period at NCI of Cairo was
4,163. Radical cystectomy with urinary diversion was
performed for 1,773 patients. Subjects with incomplete
follow up and those with one or more of the variables not
registered were excluded from the study. Among the
approved subjects we selected at random two groups of
equal size of good (GPG) and bad (BPG) prognosis. Good
prognosis was defined as survival of one year or more after
surgery without evidence oflocal recurrence or metastasis.
The size of each group was 155, based on a priori
estimation of the minimum sample size necessary to
demonstrate a difference between groups as little as 0.4
standard deviation.
For each patient, 13 factors were studied viz.: sex, age,
pathological stage of the tumour (TI, T2, T3, T4) (UICC,
1979), size (expressed as the largest diameter in cm), location
in the bladder (vault, anterior, posterior, lateral, trigone),
multiplicity, histological diagnosis (squamous, transitional,
adenocarcinoma), grade (GI, G2, G3) (UICC, 1979) as well
as presence of ova of schistoma haematobium in the
specimen, regional lymph node involvement, distant
metastasis in other organs at time of diagnosis, renal insuf-
ficiency and type of urinary diversion (rectal bladder, ileal
conduit, ileo-caecal bladder, ureterocutaneous) (El-Sebai,
1981). All patients were followed up for at least one year.
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The two groups were compared for the factors studied
first by univariate analysis: the chi-square test for qualitative
factors (Schwartz, 1980), the t-test for comparison of means
for quantitative factors (Schwartz, 1980), and the Ridit test
for comparison between two groups for ordered qualitative
factors (Fleiss, 1981). All tests are two-tailed and the
threshold of significance is fixed at the 5% level.
As a second step, discriminant analysis (Lachenbruch,
1975) was used to calculate a discriminant function which
helps to allocate any patient to one of the two prognostic
groups. This function has been based upon K variables:
x1, X2,X3, ... Xk, which were proved by univariate analysis to
be significantly different between the two prognostic groups.
Finally, a stepwise approach was used in order to
sequentially identify the factors that have a maximum dis-
criminating power between the two groups.
Results
Univariate analysis
The results of univariate analysis for the 13 factors are
summarized in Tables I and II. Nine factors proved to be
prognostic. These were:
1.Age: GPG subjects were on average younger than BGP
subjects (P<0.01).
Table I Distribution of patient characteristics which are
significantly different in the two groups
Good Bad
prognosis prognosis Statistical
Variable group group comparison
Age (years):
Range 20-65 22-75
Mean 43.4 46.5 t=2.8
s.d. 9.7 9.7 P<0.01
Tumour stage
TI 1 0.6% 0 0.0%
T2 24 5.0% 5 3.0% Ridit test
T3 123 79.0% 119 77.0% Z=5.48
T4 7 5.0% 31 20.0% P<0.001
Tumour diameter (cm)
Range 1-12 1-12
Mean 4.65 5.55 t=4.12
s.d. 1.73 2.09 P<0.001
Location of the tumour
vault 20 13.0% 16 10.3%
anterior 20 13.0% 37 24.0%
posterior 23 15.0% 22 14.0% Xdf=2.47
lateral 83 53.0% 61 39.4% P<0.02
trigone 9 6.0% 19 12.3%
Tumour grade
GI 118 76.0% 31 20.0% Ridit test
G2 30 19.0% 92 59.0% Z=12.4
G3 7 5.0% 32 21.0% P<0.001
Lymph node
involvement
No 153 99.0% 141 91.0% x2d =9.48
Yes 2 1.0% 14 9.0% P<0.01
Metastasis
No 154 99.4% 145 94.0% Xidf=7.63
Yes 1 0.6% 10 6.0% P<0.01
Renal insufficiency
No 114 74.0% 71 46.0% X2df=24.78
Yes 41 26.0% 84 54.0% P<0.01
Urinary diversion
rectal bladder 106 68.0% 102 66.0%
ileal conduit 36 23.0% 27 17.0% X3df=8.97
ileocecal bladder 7 5.0% 6 4.0% P<0.05
uretero-cutaneous 6 4.0% 20 13.0%
Table II Distribution of patient characteristics which do not differ
significantly in the two groups
Good Bad
prognosis prognosis Statistical
Variable group group comparison
Sex
Male 121 78.0% 132 85.0% Xidf=2.06
Female 34 22.0% 23 15.0%
Type of tumour
Single 146 94.0% 150 97.0% Xldf= 1.19




carcinoma 135 87.0% 137 88.0% Xldf=0.51
Transitional cell
carcinoma 15 10.0% 15 10.0%




No 38 25.0% 32 21.0% X3df=0.66
Yes 117 75.0% 123 79.0%
2. Tumour Stage: While almost all patients in the BPG
(97%) belong to categories T3 and T4, these categories were
less represented (84%) in GPG (P<0.001).
3. Tumour grade: The two groups differed in terms of
grade; GI was more frequent in the GPG than in the BPG
(76% in GPG versus 20% in BPG), (P<0.001).
4. Tumour size: The mean diameter of the tumour of GPG
subjects was smaller than that of the tumour of BPG
subjects (P<0.001).
5. Tumour location: The site of the tumour was related to
the prognosis (P=0.02). In particular the lateral and vault
location were more frequent in GPG than in BPG.
6. Regional lymph node involvement was more frequent in
BPG than GPG (P<0.01).
7. Metastasis was less frequent in GPG than in BPG
(P<0.01).
8. Techniques ofurinary diversion were different in the two
groups (P<0.05). GPG patients were more likely to have
undergone a diversion through the ileal conduit and less
likely to have had a ureterocutaneous diversion than BPG
patients.
9. Renal insufficiency was less frequent in GPG than in
BPG (P<0.01).
Four factors were found not to be prognostic viz.: sex,
multiplicity of the tumour, histopathology of the tumour and
presence of ova of schistosoma haematobium in the
specimen (Table II).
Multivariate analysis
In the first step of the multivariate analysis all the factors
which proved to be of prognostic value from the univariate
analysis were taken into account. For that purpose, the
qualitative variables 'location of the tumour' and 'urinary
diversion' were split into exclusive dichotomous variables
(Table III). To further assess the relative prognostic value of
each of the variables, successive discriminant analysis was
performed in order to highlight the best discrimination,
taking the Mahalanobis distance as a criterion.
The stepwise approach highlighted five preeminent prog-
nostic factors, ranked as follows: grade, stage, renal
insufficiency, diameter of the tumour and lymph node
involvement (as in Table IV). The remaining four factors
(age, metastasis, location of the tumour and urinary
diversion) did not significantly increase the power of the
discriminating function.832 M. RAFLA et al.
Table IH Overall discriminant analysis between the two prognostic
groups
Coefficient
Variable Coding b t P
Age (years) continuous 0.03 2.7 0.01
Stage 1 to 4 1.14 5.6 0.001
Grade 1 to 3 2.40 10.7 0.001
Diameter of the tumour
(cm) continuous 0.25 4.1 0.001
Location of the tumour:
vault (Y/N) 1/0 -1.18 0.7 NS
anterior (Y/N) 1/0 -0.06 2.5 0.02
posterior (Y/N) 1/0 -0.90 0.2 NS
lateral (Y/N) 1/0 -1.22 2.5 0.02
Lymph node involvement
(Y/N) 1/0 0.69 3.1 0.01
Metastasis (Y/N) 1/0 1.48 2.8 0.01
Renal insufficiency (Y/N) 1/0 1.47 5.2 0.001
Urinary diversion:
ileal conduit (Y/N) 1/0 -0.21 1.3 NS
ileocecal bladder (Y/N) 1/0 -0.48 0.1 NS
ureterocutaneous (Y/N) 1/0 1.06 2.9 0.01
Discriminant analysis obtained with the 9 prognostic factors (see
Table I). For dichotomous variables (Y/N) YES is coded as 1 and
NO as 0. Other qualitative variables are split into exclusive
dichotomous variables. For example, subjects with trigone location
are those who are coded NO (0) for the four other locations, or
subjects with rectal bladder as urinary diversion are those who are
coded NO (0) for the three other types of diversion. The column b
refers to the coefficients of the discriminant function. The column t
gives the value of the test of comparison of the coefficient b to
zero. The column P gives the level ofsignificance by t-test.
Table IV Stepwise discriminant analysis
Coefficient
Variable Coding b t P
Grade 1 to 3 2.36 10.7 <0.001
Stage 1 to 4 1.31 5.6 <0.001
Renal insufficiency (Y/N) 1/0 1.48 5.5 <0.001
Diameter of the tumour
(cm) continuous 0.24 3.2 <0.01
Lymph node involvement
(Y/N) 1/0 0.96 2.7 <0.01
This table shows the last step of the stepwise discirminant
analysis. The five variables are shown in descending order of
discriminating power.
The results of the final discriminant analysis with this last
set of five factors are shown in Table IV.
A linear simplified discriminating score was determined as:
X= 10 grade (1 to 3)+5 stage (1 to 4)+6 renal insufficiency
.(Y/N)+1 diameter of the tumour (cm)+4 lymph node
involvement (Y/N)
The larger the score X, the greater was the probability of a
bad prognosis for the patient.
Among all possible cut-off points, we have evaluated the
midpoint (39) between the good prognosis mean score (33)
and the bad prognosis mean score (44).
Therefore, assuming that patients with a score _<39 are
classified as the good prognosis group and >39 as the bad
prognosis group, we obtained the contingency table 'actual
versus predicted status' (Table V). From this table it may be




GPG 126 29 155
BPG 35 120 155
Total 161 149 310
seen that (126+ 120)/310=79.4% would be correctly
classified according to our model and assumption.
Discussion
The main aim of the present study was the evaluation of the
prognostic value of 13 variables measured at the time of
radical cystectomy of bilharzial bladder cancer subjects.
Most prognostic studies of bladder cancer have dealt with
survival (Osborn et al., 1982; England et al., 1981; Kishi et
al., 1981; Cifuentes Delatte et al., 1982) and a minority with
recurrence or metastasis (Dalesio et al., 1983; Pocock et al.,
1982). Moreover these prognostic studies have generally been
concerned with 'Western' bladder cancer (Osborn et al.,
1982; Dalesio et al., 1983; Pocock et al., 1982) while few
studies have dealt with bilharzial bladder cancer (Ghoneim et
al., 1972,1976,1979; Sherif and Ibrahim, 1983). -
Nine factors proved prognostic for recurrence in our study
viz: age, pathological stage of the tumour, its size, location in
the bladder, grade as well as regional lymph node
involvement, distant metastasis in other organs, renal
insufficiency and urinary diversion. Most of them also
proved to be prognostic for survival (Osborne et al 1982;
Cifuentes Delatte et al 1982; Dalesio et al 1983; Kishi et al.,
1981; England et al., 1981; Ghoneim et al., 1972,1976; Smith
& Whitmore, 1981; Varkarakis et al., 1975; Ballanger &
Ballanger, 1982). Our study did not prove the prognostic
value of multiplicity or histopathology of the tumour; some
authors concur with this conclusion while others dissent
(Ghoneim et al., 1979; Kishi et al., 1981). Presence of ova of
schistosoma haematobium in the tumour did not appear to
be prognostic and this confirms the previous work of the
present authors (Sherif & Ibrahim, 1983). Finally, contrary
to the study of Osborn et al. (1982), we did not find a
correlation between sex and the prognosis of bilharzial
bladder cancer.
Linear discriminant analysis has been used in this study to
take into account the relationship between the prognostic
variables. We have checked by other techniques that our
results would not be significantly altered of we chose a
dichotomous coding to code the semi-quantitative variables
as grade and stage.
In conclusion, we have determined two extreme profiles
for bilharzial bladder cancer subjects: Good prognosis
patients are those with a superficial tumour of the well
differentiated type with tumour <5cm in diameter, with
normal renal function and without lymph node involvement.
Patients wirh poorly differentiated infiltrating tumour,
>5cm in diameter, with renal insufficiency and with lymph
node involvement have the worst prognosis.
Prediction of outcome by utilizing our model is a point of
considerable clinical importance. Assignment to the bad
prognosis group should alert treating surgeons to the need
for more frequent follow-up of their patients and for
continuity ofmanagement.
References
BALLANGER, R. & BALLANGER, PH. (1982). Insuffisance renale
chronique par cancer vesical. Ann. Urol., 16, 165.
CIFUENTES DELATTE, L., GARCIA DE LA PENA, E. & VELA
NAVARRETE, R. (1982). Survival rates of patients with bladder
tumours. An Experience of 1,744 cases (1950-1978). Br. J. Urol.,
54, 267.
DALSIO, O., SCHULMAN, C.C., SYLVESTER, R. & 6 others (1983).
Prognostic factors in superficial bladder tumors. A study of the
European organization for research and treatment of cancer:
Genitourinary Tract Cancer Cooperative Group. J. Urol., 129,
730.PREDICTING PROGNOSIS IN BILHARZIAL BLADDER CANCER 833
EL-BOLKAINY, M. & CHU, E. (1981). In Detection of bladder cancer
associated with schistosomiasis, El-Bolkainy, M. & Chu, E. (eds)
p. 122. Al-Ahram Press: Cairo.
EL-SEBAI, I. (1981). Carcinoma of the urinary bladder in Egypt,
current clinical experience. In Detection of bladder cancer
associated with schistosomiasis, El-Bolkainy, M. & Chu, E. (eds)
p. 9. Al-Ahram Press: Cairo.
EL-SEBAI, I. (1983). Clinical aspects, staging and management of
cancer of the bilharzial bladder. In Bladder cancer, Vol. II,
Cancer of the bilharzial bladder, El-Sebai (ed) p. 29. CRC Press:
Florida.
ENGLAND, H.R., PARIS, A.M.I. & BLANDY, J.P. (1981). The
correlation of Ti bladder tumour history with prognosis and
follow-up requirements. Br. J. Urol., 53, 593.
FLEISS, J.L. (1981). Statistical Methods for Rates and Proportions,
John Wiley & Sons: New York.
GHONEIM, M.A., MANSOUR, M.A. & EL-BOLKAINY, M.N. (1972).
Radical cystectomy for carcinoma of the bilharzial bladder. Br.
J. Urol., 44, 461.
GHONEIM, M.A., EL-BOLKAINY, M.N., MANSOUR, M.A., EL-
HAMMADY, S.M. & ASHAMALLAH, A.G. (1976). Radical
cystectomy for carcinoma of the bilharzial bladder: Technique
and results. Urology, 8, 547.
GHONEIM, M.A., ASHAMALLAH, A.G., EL-HAMMADY, S.,
GABALLAH, M.A. & SOLIMAN, E.S. (1979). Cystectomy for
carcinoma of the bilharzial bladder: 138 cases 5 years later. Br.
J. Urol., 51, 541.
IBRAHIM, A.S. (1981). Epidemiology of cancer of the urinary
bladder in Egypt. Proc. first UICC conference on cancer
prevention in developing countries. Nayoga, Japan (abstract).
KISHI, K., HIROTA, T., MATSUMOTO, K., KAKIZOE, T., MURASE, T.
& FUJITA, J. (1981). Carcinoma of the bladder: A clinical and
pathological analysis of 87 autopsy cases. J. Urol., 125, 36.
LACHENBRUCH, PETER A. (1975). Discriminant analysis, Hafner
Press: New York.
OSBORN, D.E., HONAN, R.P., PALMER, M.K., BARNARD, R.J.,
McINTYRE, D. & POINTON, R.S. (1982). Factors influencing
salvage cystectomy results. Br. J. Urol., 54, 122.
POCOCK, R.D., PONDER, B.A.J., O'SULLIVAN, J.P., IBRAHIM, S.K.,
EASTON, D.F. & SHEARER, R.J. (1982). Prognostic factors in
non-infiltrating carcinoma of the bladder: A preliminary report.
Br. J. Urol., 54, 711.
SCHWARTZ, D. (1980). Methodes statistiques a l'usage des medecins
et des biologistes. Edition Flammarion: Paris, France.
SHERIF, M. & IBRAHIM, A.S. (1983). Prognostic factors in bilharzial
bladder cancer. Proc. WHO conference on urinary bladder
cancer. Edsmyr, F. & Anderson, L. (eds) Montedison Lakemedel
AB: Stockholm, Sweden.
SMITH, J.A. & WHITMORE, W.F. (1981). Regional lymph node
metastasis from bladder cancer J. Urol., 126, 591.
UICC. UNION INTERNATIONALE CONTRE LE CANCER (1979).
TNM Classification des tumeurs malignes, Third edition.
International Union against Cancer: Geneva.
VARKARAKIS, M.J., GAETA, J., MOORE, R.H. & MURPHY, G.P.
(1975). Prognosis of bladder carcinoma in patients treated with
cystectomy. Int. Urol. Nephrol, 7, 39.